Improved fibronectin-based binding molecules and uses thereof

Details for Australian Patent Application No. 2009242038 (hide)

Owner Novartis AG

Inventors Loew, Andreas; Hastewell, John

Agent Davies Collison Cave

Pub. Number AU-A-2009242038

PCT Pub. Number WO2009/133208

Priority 61/050,142 02.05.08 US

Filing date 4 May 2009

Wipo publication date 5 November 2009

International Classifications

C07K 14/78 (2006.01) Peptides having more than 20 amino acids

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

2 December 2010 PCT application entered the National Phase

  PCT publication WO2009/133208 Priority application(s): WO2009/133208

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009242050-Variable-width bogie with rotating axles and a stationary apparatus for changing track width

2009242027-Levels of APRIL in serum and use in diagnostic methods